ESC Premium Access

Favourable safety profile of S62798, a potent TAFIa (activated thrombin-activatable fibrinolysis inhibitor) inhibitor, in first-in-man study in healthy subjects

Congress Presentation

About the speaker

Mrs Florence Petit Dop

International Research Institute Servier (IRIS), Suresnes (France)
0 follower

2 more presentations in this session

Accurate and efficient non-invasive strategy for early identification of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism (InShape II study)

Speaker: Doctor E. Klok (Leiden, NL)


De-escalation/discontinuation of oxygen-therapy and medication is feasible and safe in chronic thromboembolic pulmonary hypertension patients treated with balloon pulmonary angioplasty

Speaker: Doctor M. Kimura (Tokyo, JP)


Access the full session

Advances in Chronic Thromboembolic Pulmonary Hypertension

Speakers: Mrs F. Petit Dop, Doctor E. Klok, Doctor M. Kimura

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb